Works matching AU Hoentjen, Frank


Results: 104
    1
    2

    Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6843, doi. 10.3390/jcm11226843
    By:
    • Loveikyte, Roberta;
    • Boer, Menno;
    • van der Meulen, Catharina N.;
    • ter Steege, Rinze W. F.;
    • Tack, Greetje;
    • Kuyvenhoven, Johan;
    • Jharap, Bindia;
    • Vu, My K.;
    • Vogelaar, Lauran;
    • West, Rachel L.;
    • van der Marel, Sander;
    • Römkens, Tessa E. H.;
    • Mujagic, Zlatan;
    • Hoentjen, Frank;
    • van Bodegraven, Adriaan A.;
    • van Schaik, Fiona D. M.;
    • de Vries, Annemarie C.;
    • Dijkstra, Gerard;
    • van der Meulen-de Jong, Andrea E.
    Publication type:
    Article
    3

    Relating the molecular phenotype of ulcerative colitis to the clinical course.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-90618-8
    By:
    • Madill-Thomsen, Katelynn S.;
    • Venner, Jeffery M.;
    • Parsons, Denise E.;
    • Famulski, Konrad S.;
    • Thiesen, Aducio L.;
    • Hoque, Sami;
    • Kroeker, Karen I.;
    • Wong, Karen;
    • Peerani, Farhad;
    • Dieleman, Levinus A.;
    • Hoentjen, Frank;
    • Baumgart, Daniel C.;
    • Halloran, Philip F.;
    • Halloran, Brendan P.
    Publication type:
    Article
    4
    5

    The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 6, p. 1019, doi. 10.1111/apt.18496
    By:
    • ten Bokkel Huinink, Sebastiaan;
    • Bak, Michiel T. J.;
    • Beelen, Evelien M. J.;
    • Erler, Nicole S.;
    • Silverberg, Mark S.;
    • Allez, Matthieu;
    • Hoentjen, Frank;
    • Bodelier, Alexander G. L.;
    • Dijkstra, Gerard;
    • Romberg‐Camps, Marielle;
    • de Boer, Nanne K. H.;
    • Stassen, Laurents P. S.;
    • van der Meulen – de Jong, Andrea E.;
    • West, Rachel L.;
    • van der Woude, C. Janneke;
    • van Ruler, Oddeke;
    • de Vries, Annemarie C.
    Publication type:
    Article
    6
    7

    The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1019, doi. 10.1111/apt.18496
    By:
    • ten Bokkel Huinink, Sebastiaan;
    • Bak, Michiel T. J.;
    • Beelen, Evelien M. J.;
    • Erler, Nicole S.;
    • Silverberg, Mark S.;
    • Allez, Matthieu;
    • Hoentjen, Frank;
    • Bodelier, Alexander G. L.;
    • Dijkstra, Gerard;
    • Romberg‐Camps, Marielle;
    • de Boer, Nanne K. H.;
    • Stassen, Laurents P. S.;
    • van der Meulen – de Jong, Andrea E.;
    • West, Rachel L.;
    • van der Woude, C. Janneke;
    • van Ruler, Oddeke;
    • de Vries, Annemarie C.
    Publication type:
    Article
    8
    9
    10
    11
    12

    Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 5, p. 1189, doi. 10.1002/cpt.1712
    By:
    • Biemans, Vince B.C.;
    • Woude, C. Janneke;
    • Dijkstra, Gerard;
    • Meulen‐de Jong, Andrea E.;
    • Oldenburg, Bas;
    • Boer, Nanne K.;
    • Löwenberg, Mark;
    • Srivastava, Nidhi;
    • Bodelier, Alexander G.L.;
    • West, Rachel L.;
    • Jansen, Jeroen M.;
    • Vries, Annemarie C.;
    • Haans, Jeoffrey J.L.;
    • Jong, Dirk J.;
    • Pierik, Marie J.;
    • Hoentjen, Frank
    Publication type:
    Article
    13

    Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 1044, doi. 10.1111/apt.17153
    By:
    • Volkers, Adriaan;
    • Straatmijer, Tessa;
    • Duijvestein, Marjolijn;
    • Sales, Amber;
    • Levran, Amit;
    • van Schaik, Fiona;
    • Maljaars, Jeroen;
    • Gecse, Krisztina;
    • Ponsioen, Cyriel;
    • Grootjans, Joep;
    • Hanzel, Jurij;
    • Tack, Greetje;
    • Jansen, Jeroen;
    • Hoentjen, Frank;
    • de Boer, Nanne;
    • van der Marel, Sander;
    • Dijkstra, Gerard;
    • Oldenburg, Bas;
    • Löwenberg, Mark;
    • van der Meulen, Andrea
    Publication type:
    Article
    14
    15
    16
    17

    Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 8, p. 1366, doi. 10.1111/apt.16073
    By:
    • Asscher, Vera E. R.;
    • Biemans, Vince B. C.;
    • Pierik, Marieke J.;
    • Dijkstra, Gerard;
    • Löwenberg, Mark;
    • Marel, Sander;
    • Boer, Nanne K. H.;
    • Bodelier, Alexander G. L.;
    • Jansen, Jeroen M.;
    • West, Rachel L.;
    • Haans, Jeoffrey J. L.;
    • Dop, Willemijn A.;
    • Weersma, Rinse K.;
    • Hoentjen, Frank;
    • Maljaars, P. W. Jeroen
    Publication type:
    Article
    18
    19
    20

    Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti‐TNF treatment.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 123, doi. 10.1111/apt.15745
    By:
    • Biemans, Vince B. C.;
    • Woude, C. Janneke;
    • Dijkstra, Gerard;
    • Meulen‐de Jong, Andrea E.;
    • Löwenberg, Mark;
    • Boer, Nanne K.;
    • Oldenburg, Bas;
    • Srivastava, Nidhi;
    • Jansen, Jeroen M.;
    • Bodelier, Alexander G. L.;
    • West, Rachel L.;
    • Vries, Annemarie C.;
    • Haans, Jeoffrey J. L.;
    • Jong, Dirk;
    • Hoentjen, Frank;
    • Pierik, Marieke J.
    Publication type:
    Article
    21
    22

    Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 9, p. 880, doi. 10.1111/apt.15689
    By:
    • Biemans, Vince B. C.;
    • Sleutjes, Jasmijn A. M.;
    • Vries, Annemarie C.;
    • Bodelier, Alexander G. L.;
    • Dijkstra, Gerard;
    • Oldenburg, Bas;
    • Löwenberg, Mark;
    • Bodegraven, Adriaan A.;
    • Meulen‐de Jong, Andrea E.;
    • Boer, Nanne K. H.;
    • Srivastava, Nidhi;
    • West, Rachel L.;
    • Römkens, Tessa E. H.;
    • Horjus Talabur Horje, Carmen S.;
    • Jansen, Jeroen M.;
    • Woude, C. Janneke;
    • Hoekstra, Jildou;
    • Weersma, Rinse K.;
    • Schaik, Fiona D. M.;
    • Hoentjen, Frank
    Publication type:
    Article
    23

    Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 1, p. 129, doi. 10.1111/apt.15539
    By:
    • Moens, Annick;
    • Woude, C. Janneke;
    • Julsgaard, Mette;
    • Humblet, Evelien;
    • Sheridan, Juliette;
    • Baumgart, Daniel C.;
    • Gilletta De Saint‐Joseph, Cyrielle;
    • Nancey, Stéphane;
    • Rahier, Jean‐François;
    • Bossuyt, Peter;
    • Cremer, Anneline;
    • Dewit, Sophie;
    • Eriksson, Carl;
    • Hoentjen, Frank;
    • Krause, Thomas;
    • Louis, Edouard;
    • Macken, Elisabeth;
    • Milenkovic, Zoran;
    • Nijs, Jochen;
    • Posen, Annelies
    Publication type:
    Article
    24
    25
    26
    27

    Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease.

    Published in:
    Journal of Gastrointestinal & Liver Diseases, 2016, v. 25, n. 4, p. 431, doi. 10.15403/jgld.2014.1121.254.nis
    By:
    • Nissen, Loes H. C.;
    • Assendorp, Eemke L.;
    • van der Post, Rachel S.;
    • Derikx, Lauranne A. A. P.;
    • de Jong, Dirk J.;
    • Kievit, Wietske;
    • Pierik, Marieke;
    • van den Heuvel, Tim;
    • Verhoeven, Rob;
    • Overbeek, Lucy I. H.;
    • Hoentjen, Frank;
    • Nagtegaal, Iris D.
    Publication type:
    Article
    28
    29
    30

    Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.

    Published in:
    Journal of Crohn's & Colitis, 2016, v. 10, n. 2, p. 159, doi. 10.1093/ecco-jcc/jjv189
    By:
    • van den Berg, Sophie A.;
    • de Boer, Marjon;
    • van der Meulen-de Jong, Andrea E.;
    • Jansen, Jeroen M.;
    • Hoentjen, Frank;
    • Russel, Maurice G. V. M.;
    • Mahmmod, Nofel;
    • van Bodegraven, Adriaan A.;
    • van der Woude, C. Janneke;
    • Mulder, Chris J. J.;
    • de Boer, Nanne K. H.
    Publication type:
    Article
    31
    32
    33
    34

    Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals.

    Published in:
    Expert Opinion on Drug Safety, 2022, v. 21, n. 5, p. 699, doi. 10.1080/14740338.2022.2020756
    By:
    • Geeven, Isa P. A. C.;
    • Jessurun, Naomi T.;
    • Wasylewicz, Arthur T. M.;
    • Drent, Marjolein;
    • Spuls, Phyllis I.;
    • Hoentjen, Frank;
    • van Puijenbroek, Eugène P.;
    • Vonkeman, Harald E.;
    • Grootens, Koen P.;
    • van Doorn, Martijn B. A.;
    • van Den Bemt, Bart J. F.;
    • Bekker, Charlotte L.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.

    Published in:
    Digestive Diseases & Sciences, 2025, v. 70, n. 6, p. 2087, doi. 10.1007/s10620-025-08977-1
    By:
    • van Lierop, Lisa M. A.;
    • Albino, Larissa;
    • Rosentreter, Ryan;
    • Thomas, Pepijn W. A.;
    • Lu, Cathy;
    • Siffledeen, Jesse;
    • Kroeker, Karen I.;
    • Ma, Christopher;
    • Peerani, Farhad;
    • Halloran, Brendan P.;
    • Baumgart, Daniel C.;
    • Dieleman, Levinus A.;
    • Du, Lillian;
    • Hoentjen, Frank;
    • Wong, Karen
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.

    Published in:
    Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 540, doi. 10.1093/ecco-jcc/jjad179
    By:
    • Vermeire, Séverine;
    • Hanzel, Jurij;
    • Löwenberg, Mark;
    • Ferrante, Marc;
    • Bossuyt, Peter;
    • Hoentjen, Frank;
    • Franchimont, Denis;
    • Palatka, Károly;
    • Peeters, Harald;
    • Mookhoek, Aart;
    • Hertogh, Gert de;
    • Molnár, Tamás;
    • Moerkercke, Wouter van;
    • Lobatón, Triana;
    • Clasquin, Esmé;
    • Hulshoff, Melanie S;
    • Baert, Filip;
    • D'Haens, Geert;
    • group, LOVE-UC study
    Publication type:
    Article